| Financial Year |
March 31 2023 |
| Monetary Funds |
60,080,788,300.00 |
| Held-for-trading Financial Assets |
9,840,295,103.00 |
| Notes Receivable |
8,738,103,895.00 |
| Accounts Receivable |
4,264,212,553.00 |
| Advances to Suppliers |
3,028,408,947.00 |
| Other Receivables |
4,055,084,998.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,437,183,801.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,381,711,990.00 |
| Total Current Assets |
104,635,147,482.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,850,933,067.00 |
| Investment Properties |
72,008,614.00 |
| Fixed Assetes |
81,251,470,443.00 |
| Under-construction Projects |
9,555,507,059.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,147,822,401.00 |
| R&D expenses |
-- |
| Goodwill |
1,146,799,385.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,326,593,185.00 |
| Other Non-Current Assets |
3,506,160,431.00 |
| Sub-Total of Non-Current Assets |
139,026,041,811.00 |
| Total Assets |
243,661,189,293.00 |
| Short-Term Loans |
9,688,174,707.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
248,594,962.00 |
| Accounts Payable |
5,299,527,458.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
125,928,779.00 |
| Taxes Payable |
2,162,210,267.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,594,330,484.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,505,500,636.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
32,276,847,966.00 |
| Long-term Loans |
10,096,935,564.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
313,278,686.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,639,889,591.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,806,236,305.00 |
| Total Liabilities |
45,083,084,271.00 |
| Paid-In Capital(Or Share Stock) |
5,299,302,579.00 |
| Capital Surplus |
10,524,176,641.00 |
| Surplus Reserve |
2,649,651,290.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
168,991,814,829.00 |
| Minority Stockholder's Interest |
12,472,660,656.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
186,105,444,366.00 |
| Owner's Equity（Stockholder's Equity） |
198,578,105,022.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
243,661,189,293.00 |
